pyridoxamine has been researched along with thioacetamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alharbi, FM; Alhusaini, AM; Alshanwani, AR; Arafah, MM; Badr, AM; Faddah, LM; Fayed, A; Hagar, H; Shaheen, S; Sharma, AK | 1 |
1 other study(ies) available for pyridoxamine and thioacetamide
| Article | Year |
|---|---|
A promising antifibrotic drug, pyridoxamine attenuates thioacetamide-induced liver fibrosis by combating oxidative stress, advanced glycation end products, and balancing matrix metalloproteinases.
Topics: Animals; Glycation End Products, Advanced; Liver; Liver Cirrhosis; Matrix Metalloproteinase 2; Matrix Metalloproteinases; Oxidative Stress; Pyridoxamine; Thioacetamide; Tissue Inhibitor of Metalloproteinase-1 | 2022 |